share

Spiro[5,8-Methanoquinoxaline-9,2-Oxirane] (9Ci) CAS NO 362600-06-4


Unit Price:

CAS No.:362600-06-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Spiro[5,8-Methanoquinoxaline-9,2-Oxirane] (9Ci) is a specialized spirocyclic organic compound featuring a unique fused quinoxaline-oxirane structure. This complex molecular architecture makes it a valuable advanced intermediate for research and development in fine chemical synthesis. It is primarily sought by pharmaceutical and agrochemical R&D teams for constructing novel molecular scaffolds and exploring new bioactive compounds. Its precise stereochemistry and functional groups offer significant potential for creating targeted, high-value chemical entities.

Application

  • Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and anti-infective agents.
  • Agrochemical Research: Used in developing new generations of pesticides and herbicides, leveraging its complex heterocyclic core for bioactivity.
  • Material Science: Investigated as a precursor for specialty polymers and advanced organic electronic materials due to its rigid, conjugated structure.
  • Academic & Industrial R&D: A critical compound for methodological studies in organic synthesis, including spirocyclization and heterocycle formation reactions.
  • Ligand Synthesis: Potential use in creating novel chiral ligands for asymmetric catalysis, important for producing enantiomerically pure compounds.

Basic Information

Product Name Spiro[5,8-Methanoquinoxaline-9,2-Oxirane] (9Ci)
CAS No. 362600-06-4
Molecular Formula C11H8N2O
Molecular Weight 184.20 g/mol
Synonyms Spiro[5,8-methanoquinoxaline-9,2'-oxirane]; 9-Oxa-1-azadispiro[2.0.2.4]dodeca-1,11-diene-4-carbonitrile; 1,4-Epoxy-1,4-dihydro-5,8-methanoquinoxaline; Spiro(oxirane-2,9'-[5,8]methanoquinoxaline); 362600-06-4; (9CI)-Spiro[5,8-Methanoquinoxaline-9,2-Oxirane]; Spirocyclic quinoxaline-oxirane
EINECS Contact for details

Quality Control

Our Spiro[5,8-Methanoquinoxaline-9,2-Oxirane] (9Ci) is produced under strict quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity and spectroscopic identification (NMR, IR, MS), to ensure it meets the exacting standards required for research and development applications. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting critical quality attributes. We support cGMP and ISO compliant manufacturing practices for advanced intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption. Store away from incompatible materials.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0%
Single Maximum Impurity ≤ 1.0%
Residual Solvents (GC) Complies with ICH guidelines
Water Content (KF) ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.